K. Shimamoto

发表

S. Takagi, M. Nakano, S. Saitoh, 2019, Nature.

Effect of norepinephrine infusion on plasma vasopressin levels in normal human subjects.

K. Shimamoto, M. Miyahara, 1976, The Journal of clinical endocrinology and metabolism.

Plasma antidiuretic hormone levels in patients with normal and low renin essential hypertension, and secondary hypertension.

S. Hosoda, K. Shimamoto, T. Ando, 1983, Endocrinologia japonica.

Estimated Daily Intake and Seasonal Food Sources of Quercetin in Japan

K. Shimamoto, H. Oike, M. Kobori, 2015, Nutrients.

Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts

T. Nakata, K. Shimamoto, K. Miyamoto, 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Infarct size limitation by a new Na(+)-H+ exchange inhibitor, Hoe 642: difference from preconditioning in the role of protein kinase C.

K. Shimamoto, T. Miura, T. Ogawa, 1997, Journal of the American College of Cardiology.

Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial

T. Ogihara, W. Kajiyama, K. Kario, 2015, Hypertension Research.

Insulin sensitivity and lipid metabolism in human CD36 deficiency.

T. Nakata, K. Shimamoto, M. Furuhashi, 2003, Diabetes care.

Noninvasive Assessment of Left Atrial Function by Strain Rate Imaging in Patients with Hypertension: A Possible Beneficial Effect of Renin-Angiotensin System Inhibition on Left Atrial Function

T. Nakata, K. Shimamoto, S. Yuda, 2008, Hypertension Research.

Long-term outcome of implanted cardioverter defibrillators in survivors of out-of-hospital cardiac arrest of cardiac origin.

K. Shimamoto, N. Fujii, T. Miura, 2006, Circulation journal : official journal of the Japanese Circulation Society.

Early defibrillation and circulatory support can provide better long-term outcomes through favorable neurological recovery in patients with out-of-hospital cardiac arrest of cardiac origin.

K. Shimamoto, N. Fujii, T. Miura, 2005, Circulation journal : official journal of the Japanese Circulation Society.

MitoKATP channel activation suppresses gap junction permeability in the ischemic myocardium by an ERK-dependent mechanism.

K. Shimamoto, M. Nishihara, T. Miura, 2006, Cardiovascular research.

The Importance of Home Blood Pressure Measurement for Preventing Stroke and Cardiovascular Disease in Hypertensive Patients: A Sub-Analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study, a Prospective Nationwide Observational Study

T. Ogihara, K. Shimada, S. Ito, 2008, Hypertension Research.

Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial

T. Ogihara, K. Shimada, S. Ito, 2012, Hypertension Research.

Impact of Blood Pressure Control on Cardiovascular Events in 26,512 Japanese Hypertensive Patients: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study, a Prospective Nationwide Observational Study

T. Ogihara, K. Shimada, S. Ito, 2008, Hypertension Research.

Design and Baseline Characteristics of an Observational Study in Japanese Patients with Hypertension: Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH)

T. Ogihara, K. Shimada, S. Ito, 2007, Hypertension Research.

Treatment - therapeutic lifestyle modification.

T. Funahashi, K. Shimamoto, H. Daida, 2008, Journal of atherosclerosis and thrombosis.

Quantitative Assessment of Left Ventricular and Left Atrial Functions by Strain Rate Imaging in Diabetic Patients with and without Hypertension

T. Nakata, K. Shimamoto, S. Yuda, 2009, Echocardiography.

Outcome significance of thallium-201 and iodine-123-BMIPP perfusion-metabolism mismatch in preinfarction angina.

T. Nakata, K. Shimamoto, T. Miura, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Early positive biomarker in relation to myocardial necrosis and impaired fatty acid metabolism in patients presenting with acute chest pain at an emergency room.

T. Nakata, Toru Takahashi, K. Shimamoto, 2006, Circulation journal : official journal of the Japanese Circulation Society.

Prognostic value of fatty acid imaging in patients with angina pectoris without prior myocardial infarction: comparison with stress thallium imaging

T. Nakata, K. Shimamoto, N. Tamaki, 2004, European Journal of Nuclear Medicine and Molecular Imaging.

Prognostic value of impaired myocardial fatty acid uptake in patients with acute myocardial infarction

K. Shimamoto, N. Tamaki, K. Hamabe, 2000, Nuclear medicine communications.

Two- and three-dimensional assessments of myocardial perfusion and function by using technetium-99m sestamibi gated SPECT with a combination of count- and image-based techniques

T. Nakata, K. Shimamoto, M. Hareyama, 2000, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Limitations of spontaneous reperfusion and conventional medical therapy to afford myocardial protection through antecedent angina pectoris in acute myocardial infarction

T. Nakata, K. Shimamoto, S. Yuda, 1999, Annals of Nuclear Medicine.

Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako-tsubo cardiomyopathy).

T. Nakata, K. Shimamoto, S. Yuda, 2008, American heart journal.

Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population

K. Shimamoto, S. Yuda, Marenao Tanaka, 2014, Cardiovascular Diabetology.

valsartan in elderly isolated systolic hypertension (VALISH) study: rationale and design.

T. Ogihara, K. Shimada, Y. Imai, 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

Differences in Insulin Action and Secretion, Plasma Lipids and Blood Pressure Levels between Impaired Fasting Glucose and Impaired Glucose Tolerance in Japanese Subjects

Y. Miyazaki, R. DeFronzo, K. Shimamoto, 2008, Hypertension Research.

Alteration of muscle fiber composition linking to insulin resistance and hypertension in fructose-fed rats.

Y. Miyazaki, K. Shimamoto, H. Yoshida, 1999, American journal of hypertension.

δ-Opioid receptor activation before ischemia reduces gap junction permeability in ischemic myocardium by PKC-ε-mediated phosphorylation of connexin 43

K. Shimamoto, M. Nishihara, T. Miura, 2007 .

Mitochondrial KATP channel-dependent and -independent phases of ischemic preconditioning against myocardial infarction in the rat

K. Shimamoto, T. Miura, T. Miki, 2003, Basic Research in Cardiology.

Opening of mitochondrial KATP channel occurs downstream of PKC-ε activation in the mechanism of preconditioning

K. Shimamoto, T. Miura, A. Kuno, 2002 .

Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat.

K. Shimamoto, T. Miura, M. Tanno, 2000, Journal of cardiovascular pharmacology.

Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection.

K. Shimamoto, T. Miura, K. Suzuki, 1998, Journal of cardiovascular pharmacology.

Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes.

K. Shimamoto, M. Matsuzaki, T. Miura, 1998, Cardiovascular research.

Dipyridamole Potentiates the Myocardial Infarct Size–Limiting Effect of Ischemic Preconditioning

K. Shimamoto, T. Miura, T. Ogawa, 1992, Circulation.

Does Myocardial Stunning Contribute to Infarct Size Limitation by Ischemic Preconditioning?

K. Shimamoto, T. Miura, M. Goto, 1991, Circulation.

Glycosaminoglycans affect the action of human plasma kallikrein on kininogen hydrolysis and inflammation.

K. Shimamoto, M. S. Araujo, H. Nader, 2002, International immunopharmacology.

Long-Term Site-Related Differences in the Progression and Regression of the Idiopathic Mitral Valve Prolapse Syndrome

K. Shimamoto, S. Yuda, K. Tsuchihashi, 1999, Cardiology.

Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2021, Scientific Reports.

Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension

K. Shimamoto, M. Furuhashi, N. Moniwa, 2015, Hypertension Research.

Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential Hypertension

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2003, Hypertension.

The mechanisms of insulin sensitivity improving effects of angiotensin converting enzyme inhibitor.

K. Shimamoto, N. Ura, K. Higashiura, 1999, Immunopharmacology.

Effects of aging on the insulin actions for the glucose metabolism and renal function in normotensives and essential hypertensives.

Y. Miyazaki, K. Shimamoto, N. Ura, 1998, American journal of hypertension.

Effects of the angiotensin converting enzyme inhibitor temocapril on insulin sensitivity and its effects on renal sodium handling and the pressor system in essential hypertensive patients.

Y. Miyazaki, K. Shimamoto, N. Ura, 1998, American journal of hypertension.

Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension.

Y. Miyazaki, K. Shimamoto, T. Miura, 1998, Hypertension research : official journal of the Japanese Society of Hypertension.

Asp905Tyr polymorphism of protein phosphatase 1 G subunit gene in hypertension.

T. Ogihara, J. Higaki, K. Shimamoto, 1997, Hypertension.

Trp64Arg mutation of beta3-adrenergic receptor in essential hypertension: insulin resistance and the adrenergic system.

T. Ogihara, K. Shimamoto, H. Rakugi, 1997, American journal of hypertension.

EFFECTS OF HYPERINSULINAEMIA ON RENAL FUNCTION AND THE PRESSOR SYSTEM IN INSULIN‐RESISTANT OBESE ADOLESCENTS

Y. Miyazaki, K. Shimamoto, O. Iimura, 1996, Clinical and experimental pharmacology & physiology.

Analysis of candidate genes for insulin resistance in essential hypertension.

T. Ogihara, K. Shimamoto, H. Rakugi, 1996, Hypertension research : official journal of the Japanese Society of Hypertension.

Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.

Y. Miyazaki, K. Shimamoto, H. Takizawa, 1995, American journal of hypertension.

Effects of a calcium channel blocker, manidipine, on insulin sensitivity in essential hypertensives.

Y. Miyazaki, K. Shimamoto, O. Iimura, 1995, Journal of diabetes and its complications.

Insulin sensitivity and the effects of insulin on renal sodium handling and pressor systems in essential hypertensive patients.

Y. Miyazaki, K. Shimamoto, O. Iimura, 1994 .

Insulin Sensitivity and the Effects of Insulin on Renal Sodium Handling and Pressor Systems in Essential Hypertensive Patients

Y. Miyazaki, K. Shimamoto, O. Iimura, 1994, Hypertension.

The role of renal natriuretic and depressor systems in insulin-resistant hypertensive rats.

K. Shimamoto, M. Hagiwara, H. Yoshida, 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

The effect of tumor necrosis factor-alpha on tissue specificity and selectivity to insulin signaling.

K. Shimamoto, M. Furuhashi, N. Ura, 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

Relationship between insulin-resistance and remnant-like particle cholesterol.

S. Takagi, S. Saitoh, K. Shimamoto, 2002, Atherosclerosis.

GENDER DIFFERENCE IN THE RELATIONSHIPS AMONG HYPERLEPTINEMIA, HYPERINSULINEMIA, AND HYPERTENSION

S. Takagi, K. Shimamoto, H. Takizawa, 2001, Clinical and experimental hypertension.

Role of hyperinsulinemia in atherosclerotic coronary arterial disease: studies of semi-quantitative coronary angiography.

T. Nakata, S. Saitoh, K. Shimamoto, 1999, Internal medicine.

Epidemiology of obesity: an epidemiological study in rural communities of Hokkaido, Japan.

S. Takagi, M. Nakano, S. Saitoh, 1999, Internal medicine.

The mechanisms of the improvement of insulin sensitivity by angiotensin converting enzyme inhibitor.

Y. Miyazaki, K. Shimamoto, H. Takizawa, 1996, Clinical and experimental hypertension.

Influence of aging on insulin sensitivity in essential hypertensives and normotensives.

Y. Miyazaki, K. Shimamoto, O. Iimura, 1995, Hypertension research : official journal of the Japanese Society of Hypertension.

Effects of hyperinsulinemia under the euglycemic condition on calcium and phosphate metabolism in non-obese normotensive subjects.

Y. Miyazaki, K. Shimamoto, O. Iimura, 1995, The Tohoku journal of experimental medicine.

Efficacy and mode of action of manidipine: a new calcium antagonist.

K. Shimamoto, O. Iimura, 1993, American heart journal.

Assessment of Left Ventricular Ejection Fraction Using Long‐Axis Systolic Function Is Independent of Image Quality: A Study of Tissue Doppler Imaging and M‐Mode Echocardiography

T. Nakata, K. Shimamoto, S. Yuda, 2006, Echocardiography.

Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by δ-opioid receptor activation

K. Shimamoto, T. Miura, T. Miki, 2006, Basic Research in Cardiology.

Suppression of the degradation of adenine nucleotides during ischemia may not be a sufficient mechanism for infarct size limitation by preconditioning

K. Shimamoto, T. Miura, O. Iimura, 1996, Basic Research in Cardiology.

Roles of phospho-GSK-3β in myocardial protection afforded by activation of the mitochondrial K ATP channel.

K. Shimamoto, T. Miura, Tatsuya Sato, 2010, Journal of molecular and cellular cardiology.

Activation of adenosine receptors before ischemia enhances tolerance against myocardial stunning in the rabbit heart.

K. Shimamoto, T. Miura, O. Iimura, 1996, Journal of the American College of Cardiology.

K(ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia.

S. Genda, K. Shimamoto, T. Miura, 2002, Journal of the American College of Cardiology.

ORIGINAL ARTICLE Endoplasmic Reticulum Stress in Diabetic Hearts Abolishes Erythropoietin-Induced Myocardial Protection by Impairment of Phospho–Glycogen Synthase Kinase-3�–Mediated Suppression of Mitochondrial Permeability Transition

K. Shimamoto, S. Ishikawa, T. Miura, 2022 .

Short Communication: Angiotensin II Type 1 Receptor–Mediated Upregulation of Calcineurin Activity Underlies Impairment of Cardioprotective Signaling in Diabetic Hearts

K. Shimamoto, S. Ishikawa, Takuto Maeda, 2010, Circulation research.

Intensive or standard blood pressure control in patients with a history of ischemic stroke: RESPECT post hoc analysis

Tokyo, Kazumichi Yoshida, K. Kario, 2022, Hypertension Research.

Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection.

K. Shimamoto, T. Miura, T. Miki, 2004, Cardiovascular research.

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)

Yutaka Imai, Kazuomi Kario, Hideo Matsuura, 2014, Hypertension Research.

Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial

T. Ogihara, W. Kajiyama, K. Kario, 2016, Hypertension Research.

Long-term safety and efficacy of high-dose controlled-release nifedipine (80 mg per day) in Japanese patients with essential hypertension

K. Shimamoto, M. Kajikawa, Y. Matsuda, 2015, Hypertension Research.

Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial

T. Ogihara, K. Shimada, S. Ito, 2014, Hypertension Research.

Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial1

T. Ogihara, K. Shimada, S. Ito, 2014, Journal of hypertension.

Efficacy and Safety of Long-Term Losartan Therapy Demonstrated by a Prospective Observational Study in Japanese Patients with Hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study

T. Ogihara, K. Shimada, S. Ito, 2008, Hypertension Research.

Plasma Tsukushi Concentration Is Associated with High Levels of Insulin and FGF21 and Low Level of Total Cholesterol in a General Population without Medication

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2022, Metabolites.

Effects of Angiotensin II Type 1 Receptor Gene Polymorphisms on Insulin Resistance in a Japanese General Population: The Tanno-Sobetsu Study

T. Ogihara, T. Katsuya, S. Takagi, 2006, Hypertension Research.

Guidelines for treatment of hypertension in the elderly--2002 revised version.

T. Ogihara, Y. Ouchi, K. Shimada, 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

Blockade of angiotensin II type 1 receptors suppressed free radical production and preserved coronary endothelial function in the rabbit heart after myocardial infarction.

K. Shimamoto, T. Miura, A. Kuno, 2002 .

The Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial: Rationale and Design

T. Ogihara, K. Shimada, K. Shimamoto, 2005, Hypertension Research.

Committee Report 3 Goals of Dyslipidemia Management

T. Funahashi, K. Shimamoto, H. Daida, 2007 .

Goals of dyslipidemia management.

T. Funahashi, K. Shimamoto, H. Daida, 2007, Journal of atherosclerosis and thrombosis.

Relationship Between Coronary Events and Serum Cholesterol During 10 Years of Low-Dose Simvastatin Therapy

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2008 .

Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients.

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2003, Circulation journal : official journal of the Japanese Circulation Society.

Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.

T. Nakata, K. Shimamoto, M. Travin, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Plasma noradrenaline as an indicator of functional state in hearts with mitral stenosis: The influence of acutely reduced left atrial pressure by balloon mitral commissurotomy

K. Shimamoto, H. Takizawa, O. Iimura, 2005, Heart and Vessels.

Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure.

T. Nakata, Toru Takahashi, K. Shimamoto, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction.

T. Nakata, K. Shimamoto, T. Wakabayashi, 2003, Journal of cardiac failure.

Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure

T. Nakata, Toru Takahashi, K. Shimamoto, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Primary Cardiovascular Events and Serum Lipid Levels in Elderly Japanese with Hypercholesterolemia Undergoing 6‐Year Simvastatin Treatment: A Subanalysis of the Japan Lipid Intervention Trial

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2004, Journal of the American Geriatrics Society.

Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT).

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2002, Circulation journal : official journal of the Japanese Circulation Society.

Design and baseline characteristics of a cohort study in Japanese patients with hypercholesterolemia: the Japan lipid intervention trial (J-LIT)

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2000 .

Predominant expression of Sir2α, an NAD‐dependent histone deacetylase, in the embryonic mouse heart and brain 1

K. Shimamoto, Y. Horio, T. Miura, 2004 .

Olmesartan Ameliorates Insulin Sensitivity by Modulating Tumor Necrosis Factor-α and Cyclic AMP in Skeletal Muscle

K. Shimamoto, N. Togashi, N. Ura, 2005, Hypertension Research.

Distinct Regulation of U-ACE2 and P-ACE2 (Urinary and Plasma Angiotensin-Converting Enzyme 2) in a Japanese General Population

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2021, Hypertension.

Chronic Treatment with an ACE Inhibitor, Temocapril, Lowers the Threshold for the Infarct Size–Limiting Effect of Ischemic Preconditioning

K. Shimamoto, T. Miura, A. Tsuchida, 1999, Cardiovascular Drugs and Therapy.

Elderly patients.

T. Funahashi, K. Shimamoto, H. Daida, 2008, Journal of atherosclerosis and thrombosis.

Effect of intravenous propranolol on left ventricular apical ballooning without coronary artery stenosis (ampulla cardiomyopathy): three cases.

T. Nakata, K. Shimamoto, Y. Fujise, 2002, Circulation journal : official journal of the Japanese Circulation Society.

American women ( aged 30 − 55 years at Women

T. Funahashi, K. Shimamoto, H. Daida, 2008 .

Risk Factors of Atherosclerotic Diseases

T. Funahashi, K. Shimamoto, H. Daida, 2007 .

Long-term outcome after primary stenting versus balloon angioplasty for acute myocardial infarction.

R. Noda, K. Shimamoto, K. Miyamoto, 2006, International heart journal.

A case of quadricuspid aortic valve with congestive heart failure due to juvenile hypertension

K. Shimamoto, S. Yuda, K. Tsuchihashi, 2006 .

[Insulin resistance and hypertension].

K. Shimamoto, T. Miura, 2007, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

The role of ADAM protease in the tyrosine kinase-mediated trigger mechanism of ischemic preconditioning.

K. Shimamoto, A. Nakano, T. Miura, 2004, Cardiovascular research.

Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.

T. Funahashi, K. Shimamoto, H. Daida, 2007, Journal of atherosclerosis and thrombosis.

The Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014 (JSH2014)

K. Shimamoto, 2014 .

Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial

T. Ogihara, K. Shimada, S. Ito, 2013, Hypertension Research.

Blood pressure control in Japanese hypertensives with or without type 2 diabetes mellitus.

K. Shimamoto, R. Kikkawa, T. Awata, 2000, Hypertension research : official journal of the Japanese Society of Hypertension.

Guidelines for Hypertension in the 1999 Revised Version-Elderly

T. Ogihara, M. Fujishima, K. Shimamoto, 2006 .

K. Shimamoto, C. Liau, M‐F Chen, 2006 .

A promoter polymorphism of lamin A/C gene is an independent genetic predisposition to arterial stiffness in a Japanese general population (the Tanno and Sobetsu study).

T. Ogihara, T. Katsuya, K. Shimamoto, 2009, Journal of atherosclerosis and thrombosis.

Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability

T. Ogihara, K. Shimada, S. Ito, 2014, Hypertension Research.

Treatment--drug therapy.

T. Funahashi, K. Shimamoto, H. Daida, 2008, Journal of atherosclerosis and thrombosis.

2. Recent Progress of Hypertension Diagnosis and Therapy

K. Shimamoto, 2015 .

[The cutting-edge of medicine; guidelines for managements of hypertension 2014 (JSH2014)].

K. Shimamoto, 2014, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Angiotensin II inhibits glucose uptake of skeletal muscle via the adenosine monophosphate-activated protein kinase pathway.

Y. Miyazaki, K. Shimamoto, H. Yoshida, 2007, Journal of the American Society of Hypertension : JASH.

Mechanisms of Insulin Resistance in Hypertensive Rats

K. Shimamoto, N. Ura, 2006, Clinical and experimental hypertension.

Effect of TNF-α–Converting Enzyme Inhibitor on Insulin Resistance in Fructose-Fed Rats

K. Shimamoto, N. Togashi, N. Ura, 2002 .

Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy

K. Shimamoto, T. Miura, H. Akasaka, 2014, Hypertension Research.

[Association of obesity and other cardiovascular risk factors with stroke the Japan Arteriosclerosis Longitudinal Study--Existing Cohorts Combined (JALS-ECC)].

K. Shimamoto, Y. Ohashi, Y. Kiyohara, 2011, [Nihon koshu eisei zasshi] Japanese journal of public health.

[New trends in management and treatment of hypertension (JNC-VI and the current status in Japan)].

K. Shimamoto, 1999, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension

T. Ogihara, Y. Ouchi, K. Kario, 2009, Hypertension Research.

Independent association of plasma xanthine oxidoreductase activity with hypertension in nondiabetic subjects not using medication

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2021, Hypertension Research.

Independent Association of Fatty Liver Index With Left Ventricular Diastolic Dysfunction in Subjects Without Medication.

K. Shimamoto, S. Yuda, Marenao Tanaka, 2021, The American journal of cardiology.

Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2021, Journal of diabetes investigation.

Plasma Xanthine Oxidoreductase Activity as a Novel Biomarker of Metabolic Disorders in a General Population.

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2018, Circulation journal : official journal of the Japanese Circulation Society.

Unexpected high plasma xanthine oxidoreductase activity in female subjects with low levels of uric acid.

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2018, Endocrine journal.

Local Production of Fatty Acid–Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis

K. Shimamoto, T. Sugaya, Marenao Tanaka, 2016, Arteriosclerosis, thrombosis, and vascular biology.

Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker.

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2015, American journal of hypertension.

FABP4 is secreted from adipocytes by adenyl cyclase‐PKA‐ and guanylyl cyclase‐PKG‐dependent lipolytic mechanisms

K. Shimamoto, J. Ishii, Marenao Tanaka, 2015, Obesity.

Urinary Excretion of Fatty Acid-Binding Protein 4 is Associated with Albuminuria and Renal Dysfunction

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2014, PloS one.

Associations of metabolic factors, especially serum retinol-binding protein 4 (RBP4), with blood pressure in Japanese--the Tanno and Sobetsu study.

K. Shimamoto, H. Akasaka, H. Ohnishi, 2010, Endocrine journal.

Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target.

S. Yamashita, K. Shimamoto, Y. Kiyohara, 2008, Journal of atherosclerosis and thrombosis.

10. Hypertension Treatment Based on the New Guideline.

K. Shimamoto, 2010 .

Endoplasmic Reticulum Stress in Diabetic Hearts Abolishes Erythropoietin-Induced Myocardial Protection by Impairment of Phospho-Glycogen Synthase Kinase-3-Mediated Suppression of Mitochondrial

K. Shimamoto, S. Ishikawa, T. Miura, 2009 .

Renal protective role of bradykinin B1 receptor in stroke-prone spontaneously hypertensive rats.

K. Shimamoto, M. Hagiwara, H. Yoshida, 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

What is the recommended treatment combination by patient type?

K. Shimamoto, C. Liau, M‐F Chen, 2006 .

Evaluation of atherosclerosis in hemodialysis patients

K. Shimamoto, H. Takizawa, N. Ura, 1998 .

[A prospect of hypertension treatment].

K. Shimamoto, 2011, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study.

S. Takagi, K. Shimamoto, S. Saitoh, 2005, European journal of endocrinology.

Possible impairment of transcardiac utilization of adiponectin in patients with type 2 diabetes.

K. Shimamoto, M. Nishihara, Toru Takahashi, 2004, Diabetes care.

Interruption of signal transduction between G protein and PKC-ε underlies the impaired myocardial response to ischemic preconditioning in postinfarct remodeled hearts

S. Genda, K. Shimamoto, T. Miura, 2003, Molecular and Cellular Biochemistry.

Fusion of bone marrow‐derived cells with renal tubules contributes to renal dysfunction in diabetic nephropathy

M. Fujimiya, K. Shimamoto, Marenao Tanaka, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity.

K. Shimamoto, M. Furuhashi, N. Moniwa, 2004, Journal of hypertension.

Crow-Fukase syndrome with ischemic cardiomyopathy.

T. Nakata, K. Shimamoto, H. Sasao, 2001, Internal medicine.

2. Metabolic Syndrome and Cardiovascular Disease

K. Shimamoto, 2008 .

ROLE OF RENAL DOPAMINERGIC ACTIVITY ON RENAL SODIUM‐WATER METABOLISM IN CONGESTIVE HEART FAILURE

K. Shimamoto, O. Iimura, K. Tsuchihashi, 1996, Clinical and experimental pharmacology & physiology.

Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases

K. Shimamoto, M. Furuhashi, T. Miura, 2014, Clinical Medicine Insights. Cardiology.

Insulin Sensitivity and Renal Sodium‐Water Metabolism in Obese Normotensive Subjects a

Y. Miyazaki, K. Shimamoto, O. Iimura, 1993, Annals of the New York Academy of Sciences.

Utility of serum ratio of heart-type fatty acid-binding protein to myoglobin for cardiac damage regardless of renal dysfunction.

T. Nakata, K. Shimamoto, M. Furuhashi, 2004, Circulation journal : official journal of the Japanese Circulation Society.

Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease

K. Shimamoto, G. Hotamisligil, Marenao Tanaka, 2011, PloS one.

Angiotensin II receptor activation in youth triggers persistent insulin resistance and hypertension—a legacy effect?

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2012, Hypertension Research.

Increased serum apolipoprotein B48 concentration in patients with metabolic syndrome.

K. Shimamoto, T. Teramoto, H. Ohnishi, 2009, Journal of atherosclerosis and thrombosis.

Survey of current drug therapy for elderly hypertension

K. Shimamoto, O. Iimura, Y. Takagawa, 1995 .

[Comparison of the effect of abdominal obesity on new onset of type 2 diabetes in a general Japanese elderly population with that in a non-elderly population-the Tanno and Sobetsu study].

K. Shimamoto, M. Mori, H. Ohnishi, 2011, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

Effects of cilnidipine on muscle fiber composition, capillary density and muscle blood flow in fructose-fed rats.

K. Shimamoto, N. Togashi, N. Ura, 2001, Hypertension research : official journal of the Japanese Society of Hypertension.

Risk Classification for Metabolic Syndrome and the Incidence of Cardiovascular Disease in Japan With Low Prevalence of Obesity: A Pooled Analysis of 10 Prospective Cohort Studies

K. Nakao, S. Ito, K. Shimamoto, 2021, Journal of the American Heart Association.

Metabolic syndrome.

T. Funahashi, K. Shimamoto, H. Daida, 2008, Journal of atherosclerosis and thrombosis.

Salt and Hypertension: Water‐Sodium Handling in Essential Hypertension

K. Shimamoto, O. Iimura, OSAMU IIMURA, 1993, Annals of the New York Academy of Sciences.

Relationship between Visceral Fat and Cardiovascular Disease Risk Factors: The Tanno and Sobetsu Study

Yu Chiba, S. Takagi, K. Shimamoto, 2007, Hypertension Research.

Role of microtubules in ischemic preconditioning against myocardial infarction.

K. Shimamoto, A. Nakano, T. Miura, 2004, Cardiovascular research.

Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation.

K. Shimamoto, T. Miura, O. Iimura, 1996, Journal of the American College of Cardiology.

Role of the angiotensin II type 1 receptor in preconditioning against infarction

K. Shimamoto, A. Nakano, T. Miura, 1997, Coronary artery disease.

Relationship between free radicals and adenosine in the mechanism of preconditioning: Are they interrelated or independent triggers?

K. Shimamoto, T. Miura, Katsuo Suzuki, 2000, Molecular and Cellular Biochemistry.

Contribution of both the sarcolemmal KATP and mitochondrial KATP channels to infarct size limitation by KATP channel openers: differences from preconditioning in the role of sarcolemmal KATP channels

K. Shimamoto, T. Miura, T. Miki, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

Roles of Cx43-associated protein kinases in suppression of gap junction-mediated chemical coupling by ischemic preconditioning.

K. Shimamoto, T. Miura, Takahiro Sato, 2009, American journal of physiology. Heart and circulatory physiology.

Endothelium-dependent coronary response is impaired in the myocardium at an early phase of post-infarct remodeling.

K. Shimamoto, A. Nakano, T. Miura, 2000, Japanese heart journal.

Technetium-99m Sestamibi/Tetrofosmin Myocardial Perfusion Scanning in Cardiac and Noncardiac Sarcoidosis

T. Nakata, K. Shimamoto, S. Yuda, 2001, Cardiology.

Right ventricular abnormalities assessed by myocardial single-photon emission computed tomography using technetium-99m sestamibi/tetrofosmin in right ventricle-originated ventricular tachyarrhythmias.

T. Nakata, K. Shimamoto, K. Tsuchihashi, 2000, Journal of the American College of Cardiology.

Ischemic and non-ischemic myocyte damage and antimyosin monoclonal imaging.

T. Nakata, K. Shimamoto, 1998, Japanese circulation journal.

Sustained right ventricular dyskinesis complicated by right ventricular infarction.

T. Nakata, K. Shimamoto, K. Tsuchihashi, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A case of primary aldosteronism with chronic renal failure undergoing hemodialysis treatment.

K. Shimamoto, O. Iimura, Y. Shizukuda, 1989, Endocrinologia japonica.

Body fluid balance and fractional excretions of sodium, inorganic phosphorus, potassium and free water in low renin essential hypertension.

K. Shimamoto, M. Miyahara, T. Ando, 1979, Japanese circulation journal.

Hypertensive Hypertrophied Myocardium Is Vulnerable to Infarction and Refractory to Erythropoietin-Induced Protection

K. Shimamoto, T. Miura, Tatsuya Sato, 2011, Hypertension.

Matsuda–DeFronzo insulin sensitivity index is a better predictor than HOMA-IR of hypertension in Japanese: the Tanno–Sobetsu study

Y. Miyazaki, S. Saitoh, K. Shimamoto, 2012, Journal of Human Hypertension.

Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair.

K. Shimamoto, T. Miura, T. Miki, 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Alterations in cerebrospinal fluid angiotensin II by sodium intake in patients with essential hypertension.

K. Shimamoto, Y. Kawano, S. Akabane, 1989, Clinical science.

A sensitive method for precise measurement of endogenous angiotensins I, II&III in human plasma.

K. Shimamoto, Y. Kawano, S. Akabane, 1987, Clinical and experimental hypertension. Part A, Theory and practice.

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2019, Journal of diabetes investigation.

[The significance of platelet alpha 2-adrenoceptor and sympathetic nerve activity in the hypertensive mechanism under essential hypertension--with special reference to pressor response to norepinephrine].

K. Shimamoto, O. Iimura, H. Ohshika, 1995, Nihon Naibunpi Gakkai zasshi.

A very sensitive direct radioimmunoassay system for plasma angiotensin II and its clinical application in various hypertensive diseases.

S. Hosoda, K. Shimamoto, Y. Nakahashi, 1984, Japanese circulation journal.

An improved method for the determination of human blood kinin levels by sensitive kinin radioimmunoassay.

S. Hosoda, K. Shimamoto, T. Ando, 1982, Endocrinologia japonica.

Excretion of human urinary kallikrein quantity measured by a direct radioimmunoassay of human urinary kallikrein in patients with essential hypertension and secondary hypertensive diseases.

K. Shimamoto, J. Chao, H. Margolius, 1981, Japanese circulation journal.

The radioimmunoassay of human urinary kallikrein and comparisons with kallikrein activity measurements.

K. Shimamoto, J. Chao, H. Margolius, 1980, The Journal of clinical endocrinology and metabolism.

A sensitive radioimmunoassay for the determination of plasma angiotensin II in human subjects.

K. Shimamoto, M. Miyahara, O. Moriguchi, 1979, Japanese circulation journal.

Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations

S. Takagi, K. Shimamoto, S. Saitoh, 2004, Clinical endocrinology.

Clinical diagnosis of metabolic syndrome 1. Metabolic syndrome and insulin resistance.

K. Shimamoto, S. Saitoh, N. Ura, 2007, Internal medicine.

Incidence of Type 2 Diabetes in Individuals With Central Obesity in a Rural Japanese Population

S. Takagi, K. Shimamoto, H. Akasaka, 2006, Diabetes Care.

Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway

K. Shimamoto, M. Nishihara, T. Miura, 2007, Basic Research in Cardiology.

Induction of Manganese Superoxide Dismutase by Nuclear Translocation and Activation of SIRT1 Promotes Cell Survival in Chronic Heart Failure*

K. Shimamoto, Y. Horio, S. Ishikawa, 2010, The Journal of Biological Chemistry.

Quantitative assessment of right ventricular structural abnormalities by right ventricular polar mapping of single photon emission computed tomogram

K. Shimamoto, K. Uno, T. Wakabayashi, 2002, Nuclear medicine communications.

Electrocardiographic and echocardiographic abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy and in their pedigrees.

T. Nakata, K. Shimamoto, K. Uno, 2000, The American journal of cardiology.

[Role of impaired glucose tolerance in the progression of hypertension].

K. Shimamoto, S. Tanaka, S. Saitoh, 1998, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

Guidelines for Smoking Cessation (JCS 2010)--digest version.

M. Tsuboi, J. Higaki, K. Shimamoto, 2012, Circulation journal : official journal of the Japanese Circulation Society.

Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C.

K. Shimamoto, T. Miura, A. Kuno, 2002, Journal of the American College of Cardiology.

Olmesartan Is an Angiotensin II Receptor Blocker with an Inhibitory Effect on Angiotensin-Converting Enzyme

K. Shimamoto, H. Yoshida, N. Ura, 2006, Hypertension Research.

Resveratrol Improves Cardiomyopathy in Dystrophin-deficient Mice through SIRT1 Protein-mediated Modulation of p300 Protein*

K. Shimamoto, Y. Horio, T. Miura, 2013, The Journal of Biological Chemistry.

Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: detection with iodine-123-MIBG.

T. Nakata, K. Shimamoto, O. Iimura, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Diagnostic implications of modified treadmill and head-up tilt tests in exercise-related syncope: comparative studies with situational and/or vasovagal syncope.

T. Nakata, K. Shimamoto, K. Uno, 2002, The Canadian journal of cardiology.

Plasma and urinary ADH levels in patients with essential hypertension.

K. Shimamoto, M. Miyahara, T. Ando, 1979, Japanese circulation journal.

DO ANGIOTENSIN CONVERTING ENZYME INHIBITORS LIMIT MYOCARDIAL INFARCT SIZE?

K. Shimamoto, T. Miura, O. Iimura, 1993, Clinical and experimental pharmacology & physiology.

Angiotensin‐Converting Enzyme Inhibitors and the Kallikrein‐Kinin System

K. Shimamoto, O. Iimura, T. Matsuki, 1990, Journal of cardiovascular pharmacology.

A study of plasma vasopressin in patients undergoing chronic hemodialysis.

K. Shimamoto, M. Miyahara, I. Watarai, 1977, The Journal of clinical endocrinology and metabolism.

Human plasma inactive renin: purification and activation by proteases.

K. Shimamoto, J. Chao, T. Inagami, 1982, The Journal of clinical endocrinology and metabolism.

The pathophysiological role of kinin and chemical mediators on experimental allergic rhinitis.

K. Shimamoto, A. Kataura, O. Iimura, 1989, Advances in experimental medicine and biology.

Release of kinin and other chemical mediators after antigenic stimulation in allergic rhinitis patients.

K. Shimamoto, A. Kataura, O. Iimura, 1989, Advances in experimental medicine and biology.

Predictive values of serum insulin kinetics for reversion of impaired glucose tolerance to normal glucose tolerance and the effects of voglibose treatment: a retrospective post hoc analysis of a Japanese phase III study

K. Shimamoto, N. Tajima, Y. Iwamoto, 2012, Diabetology International.

Suppression of reperfusion arrhythmias by preconditioning is inhibited by an ATP-sensitive potassium channel blocker, 5-hydroxydecanoate, but not by protein kinase C blockers in the rat.

K. Shimamoto, T. Miura, A. Tsuchida, 1998, Journal of cardiovascular pharmacology.

Clinical Efficacy of a New Angiotensin II Type 1 Receptor Blocker, Pratosartan, in Hypertensive Patients

T. Ogihara, K. Shimamoto, T. Saruta, 2008, Hypertension Research.

Increased production of angiotensin II in the adrenal gland of stroke-prone spontaneously hypertensive rats with malignant hypertension.

K. Shimamoto, M. Hosoi, S. Kim, 1991, Biochemical and biophysical research communications.

The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in rats.

K. Shimamoto, O. Iimura, N. Ura, 1994, Clinical and experimental hypertension.

Effects of neutral endopeptidase 24.11 inhibition on myocardial infarct size and ischemic preconditioning in rabbits

K. Shimamoto, A. Nakano, T. Miura, 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

Myocardial accumulation of monoclonal antimyosin Fab in hypertrophic cardiomyopathy and postpartum cardiomyopathy.

T. Nakata, K. Shimamoto, S. Tanaka, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Suppression of reperfusion arrhythmia by ischemic preconditioning in the rat: Is it mediated by the adenosine receptor, prostaglandin, or bradykinin receptor?

K. Shimamoto, T. Miura, O. Iimura, 1995, Basic Research in Cardiology.

An enzymatic cycling method for the measurement of myo-inositol in biological samples.

K. Shimamoto, N. Ura, M. Takahashi, 2001, Clinica chimica acta; international journal of clinical chemistry.

Ser9 phosphorylation of mitochondrial GSK-3beta is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis.

K. Shimamoto, Y. Horio, S. Ishikawa, 2008, American journal of physiology. Heart and circulatory physiology.

Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2021, Journal of atherosclerosis and thrombosis.

Protease Inhibitors Extracted from Caesalpinia echinata Lam. Affect Kinin Release during Lung Inflammation

K. Shimamoto, M. S. Araujo, A. Tanaka, 2016, Pulmonary medicine.

Permeability of antidiuretic hormone and other hormones through the dialysis membrane in patients undergoing chronic hemodialysis.

K. Shimamoto, M. Miyahara, T. Ando, 1977, The Journal of clinical endocrinology and metabolism.

Immunoreactive tissue kallikrein in human serum.

K. Shimamoto, J. Chao, R. Mayfield, 1984, The Journal of laboratory and clinical medicine.

A sensitive radioimmunoassay method for urinary kinins in man.

K. Shimamoto, M. Miyahara, T. Ando, 1978, The Journal of laboratory and clinical medicine.

Indication And Efficacy Of Percutaneous Cardiopulmonary Support In Patients With Out-Of-Hospital Cardiac Arrest

K. Shimamoto, Y. Kurimoto, S. Nara, 2003 .

Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection.

K. Shimamoto, M. Nishihara, T. Miura, 2007, Journal of molecular and cellular cardiology.

Annual change in plasma xanthine oxidoreductase activity is associated with changes in liver enzymes and body weight.

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2019, Endocrine journal.

Studies on the Mechanism of the Antihypertensive Effect of Long-Term Administered Nifedipine in Patients with Benign Essential Hypertension

K. Shimamoto, O. Iimura, K. Kikuchi, 1989 .

Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism?

Y. Miyazaki, K. Shimamoto, O. Iimura, 1994, Journal of human hypertension.

The Role of Nitric Oxide and Kinin on the Renal Water-Sodium Metabolism

K. Shimamoto, Y. Takagawa, N. Ura, 1999 .

The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in normotensive and hypertensive rats.

K. Shimamoto, O. Iimura, Y. Takagawa, 1995, Clinical and experimental hypertension.

The mechanisms of the renal effects of neutral endopeptidase inhibitor in rats.

K. Shimamoto, O. Iimura, Y. Takagawa, 1995, Clinical and experimental hypertension.

Delayed onset of pulmonary hypertension associated with an appetite suppressant, mazindol: a case report.

K. Shimamoto, M. Hagiwara, T. Asai, 2000, Japanese circulation journal.

Critical timing of mitochondrial KATP channel opening for enhancement of myocardial tolerance against infarction

S. Genda, K. Shimamoto, T. Miura, 2001, Basic Research in Cardiology.

The radioimmunoassay for human plasma atrial natriuretic peptide--its application to uremic patients.

K. Shimamoto, T. Ando, M. Nakagawa, 1987, Japanese journal of medicine.

Right bundle branch block and coved-type ST-segment elevation mimicked by acute cholecystitis.

K. Shimamoto, M. Furuhashi, K. Uno, 2003, Circulation journal : official journal of the Japanese Circulation Society.

Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.

K. Shimamoto, O. Iimura, 1989, Advances in experimental medicine and biology.

LIMITATION OF INFARCT SIZE BY ERYTHROPOIETIN IS ASSOCIATED WITH TRANSLOCATION OF Akt TO THE MITOCHONDRIA AFTER REPERFUSION

K. Shimamoto, T. Miura, H. Ishida, 2008, Clinical and experimental pharmacology & physiology.

Massive myocardial calcification of right and left ventricles following acute myocarditis complicated with rhabdomyolysis-induced acute renal failure.

T. Nakata, K. Shimamoto, O. Iimura, 1993, Japanese circulation journal.

Direct evidence for local generation and release of angiotensin II in human vascular tissue.

K. Shimamoto, T. Inagami, K. Mizuno, 1989, Biochemical and biophysical research communications.

Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation

T. Nakata, K. Shimamoto, K. Uno, 2001, Pacing and clinical electrophysiology : PACE.

Localization of renal kallikrein-kinin system components in the kidney.

K. Shimamoto, T. Ando, O. Iimura, 1986, Japanese journal of medicine.

K. Shimamoto, 2007, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

ER stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-GSK-3 β -mediated suppression of mitochondrial permeability transition.

K. Shimamoto, S. Ishikawa, T. Miura, 2009 .

[Significance of accumulation of arteriosclerotic risk factors in elderly people: from a study conducted in Tanno-Sobetsz].

S. Takagi, S. Saitoh, K. Shimamoto, 1998, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

Scintigraphic evidence for a specific long-chain fatty acid transporting system deficit and the genetic background in a patient with hypertrophic cardiomyopathy.

T. Nakata, K. Shimamoto, K. Kawamura, 1999, Japanese circulation journal.

[Hypertension treatment for elderly hypertension].

K. Shimamoto, 2003, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

Effects of angiotensin II receptor blockade on glucose metabolism via AMP-activated protein kinase in insulin-resistant hypertensive rats.

Y. Miyazaki, K. Shimamoto, H. Yoshida, 2009, Journal of the American Society of Hypertension : JASH.

[Mechanism of inhibition of aldosterone secretion by a Ca2+ channel blocker in patients with essential hypertension and patients with primary aldosteronism].

K. Shimamoto, T. Yokoyama, O. Iimura, 1995, Nihon Naibunpi Gakkai zasshi.

Delayed visceral bleeding from liver injury after cardiopulmonary resuscitation.

K. Shimamoto, T. Miura, K. Tsuchihashi, 2012, The Journal of emergency medicine.

Resveratrol Ameliorates Muscular Pathology in the Dystrophic mdx Mouse, a Model for Duchenne Muscular Dystrophy

K. Shimamoto, Y. Horio, T. Miura, 2011, Journal of Pharmacology and Experimental Therapeutics.

K. Shimamoto, T. Kijima, S. Tanaka, 1991, Japanese heart journal.

What are the education programmes needed for doctors and patients in the promotion of blood pressure control?

K. Shimamoto, C. Liau, M‐F Chen, 2006 .

Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly: Valsartan in Elderly Isolated Systolic Hypertension Study

T. Ogihara, K. Shimada, Y. Imai, 2010, Hypertension.

Mitochondrial ATP-sensitive K+ channels play a role in cardioprotection by Na+-H+ exchange inhibition against ischemia/reperfusion injury.

Yongge Liu, K. Shimamoto, A. Nakano, 2001, Journal of the American College of Cardiology.

Incidence of Hypertension in Individuals with Abdominal Obesity in a Rural Japanese Population: The Tanno and Sobetsu Study

K. Shimamoto, M. Mori, H. Akasaka, 2008, Hypertension Research.

[The Tanno and Sobetsu study].

K. Shimamoto, H. Ohnishi, S. Saitoh, 2010, Nihon rinsho. Japanese journal of clinical medicine.

[The role of endogenous digitalis-like factor on hypertensive mechanisms in reduced renal mass hypertensive rats].

K. Shimamoto, O. Iimura, H. Nakagawa, 1993, Nihon Naibunpi Gakkai zasshi.

Reperfusion arrhythmias in the murine heart: their characteristics and alteration after ischemic preconditioning

K. Shimamoto, T. Miura, J. Sakamoto, 1999, Basic Research in Cardiology.

The role of bradykinin B1 receptor on cardiac remodeling in stroke-prone spontaneously hypertensive rats (SHR-SP)

K. Shimamoto, N. Moniwa, M. Hagiwara, 2006, Biological chemistry.

Suppressed dopaminergic activity and water-sodium handling in the kidneys at the prehypertensive stage of essential hypertension.

K. Shimamoto, O. Iimura, 1990, Journal of autonomic pharmacology.

The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertension.

K. Shimamoto, T. Ando, O. Iimura, 1987, Agents and actions. Supplements.

Treatment Resistant Depression Development From Major Depressive Disorder: A Claims Database Analysis In Japan

K. Shimamoto, D. Fife, J. Mahlich, 2016 .

A FAMILY WITH LIDDLE'S SYNDROME CAUSED BY A MUTATION IN THE β SUBUNIT OF THE EPITHELIAL SODIUM CHANNEL

K. Shimamoto, H. Takizawa, N. Ura, 2001, Clinical and experimental hypertension.

The contribution of nitric oxide to diuretic and natriuretic effects of renal kinins in normotensive rats.

K. Shimamoto, Y. Takagawa, N. Ura, 1999, Hypertension research : official journal of the Japanese Society of Hypertension.

Significance of renal kininases in patients with primary aldosteronism.

K. Shimamoto, O. Iimura, Y. Takagawa, 1995, Clinical and experimental hypertension.

Renal Kininase I, Kininase II and Neutral Endopeptidase 24.11 Activities in Patients with Essential Hypertension, Primary Aldosteronism and Cushing's Syndrome

K. Shimamoto, O. Iimura, N. Ura, 1993 .

Renal kininases in primary aldosteronism.

K. Shimamoto, T. Ando, S. Tanaka, 1989, Advances in experimental medicine and biology.

Physiological role of renal kallikrein-kinin system in human.

K. Shimamoto, O. Iimura, 1989, Advances in experimental medicine and biology.

Localization of neutral endopeptidase in the kidney determined by the stop-flow method.

K. Shimamoto, T. Ando, N. Ura, 1989, Advances in experimental medicine and biology.

The Analytical Value for Kinin Concentration in Blood Depends on the Antiserum Used in the Bradykinin Radioimmunoassay

K. Shimamoto, G. Bönner, D. Iwersen, 1987, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Urinary excretions of kininase I and kininase II activities in essential hypertension. A sensitive and simple method for its kinin-destroying capacity.

K. Shimamoto, S. Tanaka, O. Iimura, 1985, Journal of clinical hypertension.

The role of the renal kallikrein-kinin system in sodium metabolism in normal and low renin essential hypertension.

K. Shimamoto, T. Ando, S. Tanaka, 1983, Japanese circulation journal.

Cardiac denervation in amyloid polyneuropathy

T. Nakata, K. Shimamoto, 2003, The Lancet.

Re-evaluation of the plasma renin-angiotensin system in anephric patients.

K. Shimamoto, T. Inagami, K. Mizuno, 1990, Clinical and experimental hypertension. Part A, Theory and practice.

Infarct Size Limitation by Bradykinin Receptor Activation Is Mediated by the Mitochondrial But Not by the Sarcolemmal KATP Channel

S. Genda, K. Shimamoto, T. Miura, 2000, Cardiovascular Drugs and Therapy.

Opening of mitochondrial K(ATP) channel occurs downstream of PKC-epsilon activation in the mechanism of preconditioning.

K. Shimamoto, T. Miura, A. Kuno, 2002, American journal of physiology. Heart and circulatory physiology.

Sympathetically induced myocardial ischaemia causes the heart to release plasma kinin.

S. Hosoda, T. Nakata, K. Shimamoto, 1987, Cardiovascular research.

Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair.

K. Shimamoto, T. Miura, P. Whittaker, 2006, Journal of the American College of Cardiology.

Genome-wide association study of coronary artery disease in the Japanese

T. Ogihara, T. Ohkubo, Y. Imai, 2011, European Journal of Human Genetics.

The role of renal natriuretic depressor systems on hypertensive mechanisms in reduced renal mass hypertensive rats.

K. Shimamoto, O. Iimura, M. Nakagawa, 1995, Hypertension research : official journal of the Japanese Society of Hypertension.

Cardiac sympathetic nerve imaging in patients with heart failure or lethal arrhythmias: risk stratification and assessment of therapeutic interventions

T. Nakata, R. Noda, K. Shimamoto, 2004 .

Impaired exercise-related myocardial uptake of technetium-99m-tetrofosmin in relation to coronary narrowing and diabetic state: assessment with quantitative single photon emission computed tomography.

T. Nakata, K. Shimamoto, A. Doi, 2001, Japanese heart journal.

Implication of clinical studies for the Asian population: focus on Chinese/Asian population

Zhanghua Wu, K. Shimamoto, C. Liau, 2006 .

Endogenous immunoreactive ouabain-like and digoxin-like factors in reduced renal mass hypertensive rats.

K. Shimamoto, H. Yoshida, M. Nakagawa, 1998, Hypertension research : official journal of the Japanese Society of Hypertension.

Inhibition of thromboxane A2 synthetase failed to limit myocardial infarct size in a rabbit ischemia-reperfusion model.

K. Shimamoto, T. Miura, O. Iimura, 1991, Japanese circulation journal.

Insulin Sensitivity and Lipid Metabolism in Human Cd36 Deficiency O R I G I N a L a R T I C L E

T. Nakata, K. Shimamoto, M. Furuhashi, 2022 .

Renin Inhibitor and Converting Enzyme Inhibitors Suppress Vascular Angiotensin II

T. Ogihara, K. Shimamoto, M. Miyazaki, 1989, Hypertension.

Effect of vasodilator prostaglandins on the vascular renin-angiotensin system.

T. Ogihara, K. Shimamoto, H. Rakugi, 1988, Life sciences.

Erythropoietin (EPO) Affords More Potent Cardioprotection by Activation of Distinct Signaling to Mitochondrial Kinases Compared with Carbamylated EPO

K. Shimamoto, T. Miura, Takahiro Sato, 2010, Cardiovascular Drugs and Therapy.

The Spectrum of Findings in Supra-Aortic Takayasu’s Arteritis as Seen on Spiral CT Angiography and Digital Subtraction Angiography

T. Nakata, K. Shimamoto, M. Hareyama, 2001, CardioVascular and Interventional Radiology.

Prognostic implications of left atrial dilation evaluated by echocardiographic volume in patients with normal left atrial antero-posterior dimensions

T. Nakata, K. Shimamoto, S. Yuda, 2009, Journal of echocardiography.

Hypoparathyroidism Potentiates Cardiovascular Complications through Disturbed Calcium Metabolism: Possible Risk of Vitamin D3 Analog Administration in Dialysis Patients with End-Stage Renal Disease

T. Nakata, K. Shimamoto, S. Yuda, 2000, Nephron.

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)

T. Ogihara, K. Kario, K. Shimada, 2009, Hypertension Research.

Guidelines for hypertension in the elderly--1999 revised version. Ministry of Health and Welfare of Japan.

T. Ogihara, M. Fujishima, K. Shimamoto, 1999, Hypertension research : official journal of the Japanese Society of Hypertension.

Association between senescence‐related uncoupling protein 2 gene polymorphisms and abdominal obesity in Japanese subjects: The Tanno and Sobetsu study

T. Ogihara, T. Katsuya, K. Shimamoto, 2006 .

A case of adrenal tumor producing renin, aldosterone, and sex steroid hormones.

T. Ogihara, T. Nakata, K. Shimamoto, 1986, Hypertension.

Strain rate imaging for noninvasive functional quantification of the left atrium: comparative studies in controls and patients with atrial fibrillation.

T. Nakata, K. Shimamoto, S. Yuda, 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Plasma levels of human atrial natriuretic peptide in patients with hypertensive diseases.

K. Shimamoto, T. Ando, H. Ishida, 1987, Canadian journal of physiology and pharmacology.

Activation of the δ-opioid Receptor Induces Phosphorylation of Connexin43 at Ser368 by PKC-ε and Reduces Myocardial Infarct Size(Myocardial Ischemia-reperfusion, Basic 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)

K. Shimamoto, T. Miura, T. Miki, 2005 .

[Guideline for the managements of hypertension -blood pressure control for the elderly hypertension].

K. Shimamoto, 2011, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

Primary hyperlipidemia.

T. Funahashi, K. Shimamoto, H. Daida, 2008, Journal of atherosclerosis and thrombosis.

Independent Link Between Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and FABP4 in a General Population Without Medication.

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2016, The American journal of cardiology.

Sonoclot coagulation analysis: new bedside monitoring for determination of the appropriate heparin dose during haemodialysis.

K. Shimamoto, M. Furuhashi, T. Miura, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Quantification of limited augmentation of myocardial 99mTc-tetrofosmin uptake at exercise in stable coronary artery disease

K. Shimamoto, K. Miyamoto, H. Sasao, 2001, Nuclear medicine communications.

Appropriate hematocrit levels of erythropoietin supplementary therapy in end-stage renal failure complicated by coronary artery disease.

T. Nakata, K. Shimamoto, K. Tsuchihashi, 1997, The Canadian journal of cardiology.

An ectopic, ACTH producing, oncocytic carcinoid tumor of the thymus: report of a case.

K. Shimamoto, O. Iimura, T. Mito, 1984, Japanese journal of medicine.

The anatomical architecture is a critical determinant for atrial flutter reentrant circuit : Studies of electrophysiological properties and intracardiac echocardiography

K. Shimamoto, K. Uno, K. Miyamoto, 2002 .

Blockade of the Na+-Ca2+ Exchanger is More Efficient than Blockade of the Na+-H+ Exchanger for Protection of the Myocardium from Lethal Reperfusion Injury

S. Genda, K. Shimamoto, T. Miura, 2002, Cardiovascular Drugs and Therapy.

Exercise-induced STV1 elevation: a sign of right ventricular dysfunction in recent inferior myocardial infarction.

K. Shimamoto, S. Tanaka, O. Iimura, 1994, The Canadian journal of cardiology.

The role of renal kallikrein-kinin system and prostaglandins in diuresis and natriuresis following saline infusion in normotensives and essential hypertensives.

K. Shimamoto, S. Tanaka, O. Iimura, 1986, Advances in experimental medicine and biology.

A case of swallow syncope induced by vagovagal reflex.

K. Shimamoto, O. Iimura, Y. Fujise, 1990, Japanese journal of medicine.

[Metabolic syndrome: epidemiology].

K. Shimamoto, 2004, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Inhibition of plasma kallikrein with aprotinin in porcine endotoxin shock.

K. Shimamoto, M. Siebeck, L. Schweiberer, 1993, The Journal of trauma.

Heparin affects the interaction of kininogen on endothelial cells.

K. Shimamoto, M. S. Araujo, H. Nader, 2011, Biochimie.

[Evaluation by specialists of the Guidelines on Treatment of Hypertension in the Elderly--the second questionnaire survey].

T. Ogihara, K. Shimamoto, K. Kohara, 1997, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[Therapeutic policy for elderly hypertensives in Japan--a questionnaire survey of specialists].

T. Ogihara, M. Fujishima, Y. Ouchi, 1994, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

The method of urinary total kallikrein and prekallikrein measurement, and their urinary excretions in the patients with essential hypertension.

S. Hosoda, K. Shimamoto, T. Nishitani, 1986, Advances in experimental medicine and biology.

A method for determination of human urinary inactive kallikrein (prekallikrein).

K. Shimamoto, J. Chao, H. Margolius, 1982, The Tohoku journal of experimental medicine.

Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation.

K. Shimamoto, A. Nakano, T. Miura, 2000, Circulation.

Guidelines for Hypertension in the Elderly

T. Ogihara, M. Fujishima, K. Shimamoto, 1999 .

Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance

K. Shimamoto, N. Tajima, Y. Iwamoto, 2009, The Lancet.

EFFECT OF NICORANDIL ON POST‐ISCHAEMIC CONTRACTILE DYSFUNCTION IN THE HEART: ROLES OF ITS ATP‐SENSITIVE K’ CHANNEL OPENING PROPERTY AND NITRATE PROPERTY

K. Shimamoto, T. Miura, O. Iimura, 1993, Clinical and experimental pharmacology & physiology.

Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose: the Tanno and Sobetsu study.

S. Takagi, K. Shimamoto, H. Ohnishi, 2003, Diabetes care.

A case of lactate dehydrogenase (LDH)-IgG complex formation which causes low plasma LDH activity and an abnormal LDH isozyme pattern.

K. Shimamoto, O. Iimura, T. Sasaki, 1986, Japanese journal of medicine.

The interference of acebutolol administration in the measurement of urinary 17-ketosteroid by Zimmermann's method.

K. Shimamoto, O. Iimura, M. Nakagawa, 1988, Endocrinologia japonica.

Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta.

K. Shimamoto, M. Nishihara, T. Miura, 2006, American journal of physiology. Heart and circulatory physiology.

Leptin gene polymorphism is associated with hypertension independent of obesity.

T. Ogihara, J. Higaki, T. Katsuya, 2002, The Journal of clinical endocrinology and metabolism.

Association of Pro12Ala polymorphism of PPARgamma gene with insulin resistance and related diseases.

T. Ogihara, K. Shimamoto, H. Ikegami, 2004, Diabetes research and clinical practice.

Anal ysis of Candidate Genes for Insulin in Essential Hypertension Resistance

T. Ogihara, K. Shimamoto, H. Rakugi, 2006 .

Nucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1*

K. Shimamoto, Y. Horio, T. Miura, 2007, Journal of Biological Chemistry.

Gene Polymorphism of Myospryn (Cardiomyopathy-Associated 5) Is Associated with Left Ventricular Wall Thickness in Patients with Hypertension

T. Ogihara, Y. Kaneda, R. Morishita, 2007, Hypertension Research.

Genome-wide response to antihypertensive medication using home blood pressure measurements: a pilot study nested within the HOMED-BP study.

T. Ogihara, J. Staessen, L. Thijs, 2013, Pharmacogenomics.

Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19

K. Shimamoto, M. Furuhashi, N. Moniwa, 2020, Hypertension Research.

The Work-Hardening Process in Metals

K. Shimada, K. Shimamoto, Y. Ohashi, 1969 .

A direct radioimmunoassay of rat urinary kallikrein and comparison with other measures of urinary kallikrein activity.

K. Shimamoto, J. Chao, H. Margolius, 1979, Journal of Laboratory and Clinical Medicine.

Roles of mitochondrial ATP-sensitive K channels and PKC in anti-infarct tolerance afforded by adenosine A1 receptor activation.

Yongge Liu, K. Shimamoto, T. Miura, 2000, Journal of the American College of Cardiology.

Metabolic Syndrome and Cardiac Disease in Japanese Men: Applicability of the Concept of Metabolic Syndrome Defined by the National Cholesterol Education Program–Adult Treatment Panel III to Japanese Men—The Tanno and Sobetsu Study

S. Takagi, K. Shimamoto, H. Ohnishi, 2005, Hypertension Research.

Gender difference in coronary events in relation to risk factors in Japanese hypercholesterolemic patients treated with low-dose simvastatin.

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2006, Circulation journal : official journal of the Japanese Circulation Society.

Kinin generation by hemodialysis membranes as a possible cause of anaphylactoid reactions.

K. Shimamoto, H. Lemke, L. Verresen, 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Caiman crocodilus yacare plasma kininogen detection.

K. Shimamoto, C. Sampaio, O. Iimura, 1996, Immunopharmacology.

Preliminary characterization of a Kazal-type serine protease inhibitor from Caiman crocodilus yacare plasma.

K. Shimamoto, E. Auerswald, C. Sampaio, 1999, Immunopharmacology.

Kallikrein in the male reproductive system.

S. Saitoh, K. Shimamoto, O. Iimura, 1987, Archives of andrology.

Mechanisms of Suppression of Renal Kallikrein Activity in Low Renin Essential Hypertension and Renoparenchymal Hypertension

K. Shimamoto, T. Ando, M. Nakagawa, 1989, Hypertension.

The tissue kallikrein-kinin system in human seminal plasma--biochemical and functional aspects.

F. Fiedler, K. Shimamoto, W. Schill, 1986, Advances in experimental medicine and biology.

Urinary kallikrein in Dahl-Iwai salt-sensitive and -resistant rats.

K. Shimamoto, H. Takizawa, H. Yoshida, 1997, American journal of hypertension.

Japanese Society for Dialysis Therapy Guidelines for Management of Cardiovascular Diseases in Patients on Chronic Hemodialysis

K. Tabei, K. Shimamoto, K. Kugiyama, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

A case of congenital left ventricular diverticulum with pulmonary stenosis and its scintigraphic characteristics.

T. Nakata, K. Shimamoto, O. Iimura, 1991, Japanese circulation journal.

The effect of blood volume changes accompanying isotonic circumstances on plasma antidiuretic hormone levels in normal subjects.

K. Shimamoto, T. Ando, T. Nishitani, 1985, Japanese journal of medicine.

Prevalence of asymptomatic arteriosclerosis obliterans and its relationship with risk factors in inhabitants of rural communities in Japan: Tanno-Sobetsu study.

S. Takagi, K. Shimamoto, H. Akasaka, 2004, Atherosclerosis.

Pseudoaneurysm of the Superficial Femoral Artery in Behçet's Disease with Spontaneous Thrombosis Followed by CT Angiography

K. Shimamoto, M. Hareyama, H. Akiba, 1998, Cardiovascular and Interventional Radiology.

High plasma immunoreactive leptin level in essential hypertension.

Y. Miyazaki, K. Shimamoto, J. Agata, 1997, American journal of hypertension.

The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.

K. Shimamoto, H. Takizawa, K Higashiura, 2000, American journal of hypertension.

Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension

Y. Miyazaki, K. Shimamoto, N. Ura, 1999, Journal of Human Hypertension.

Chinese medicine, Jiang-Tang-Ke-Li, improves insulin resistance by modulating muscle fiber composition and muscle tumor necrosis factor-alpha in fructose-fed rats.

K. Shimamoto, T. Miura, N. Ura, 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

Effects of the Chinese medicine Jiang-Tang-Ke-Li on insulin resistance in fructose-fed rats.

S. Saitoh, K. Shimamoto, N. Togashi, 2001, Hypertension research : official journal of the Japanese Society of Hypertension.

The contribution of skeletal muscle tumor necrosis factor‐α to insulin resistance and hypertension in fructose‐fed rats

K. Shimamoto, N. Togashi, N. Ura, 2000, Journal of hypertension.

Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2002, Circulation journal : official journal of the Japanese Circulation Society.

Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations.

T. Nakata, K. Shimamoto, K. Itakura, 2001, Journal of lipid research.

Low Adiponectin Level in Young Normotensive Men with a Family History of Essential Hypertension

Y. Miyazaki, K. Shimamoto, M. Furuhashi, 2005, Hypertension Research.

Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension.

K. Shimamoto, N. Moniwa, Y. Takagawa, 2004, Circulation journal : official journal of the Japanese Circulation Society.

Role of adiponectin in insulin-resistant hypertension and atherosclerosis.

K. Shimamoto, M. Furuhashi, T. Miura, 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

CHANGES OF URINARY DOPAMINE EXCRETION EARLY AFTER BALLOON MITRAL COMMISSUROTOMY IN MITRAL STENOSIS

K. Shimamoto, H. Takizawa, K. Tsuchihashi, 1999, Clinical and experimental pharmacology & physiology.

Quantitative Measurement of Circumferential Carotid Arterial Strain by Two‐Dimensional Speckle Tracking Imaging in Healthy Subjects

K. Shimamoto, S. Yuda, T. Miura, 2011, Echocardiography.

Study on the renal kallikrein-kinin system in normal and low renin subgroups of essential hypertension.

K. Shimamoto, S. Tanaka, O. Iimura, 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Tissue kallikrein of human seminal plasma is secreted by the prostate gland.

F. Fiedler, K. Shimamoto, W. Schill, 1985, Biological chemistry Hoppe-Seyler.

A simple and sensitive method for determination of human urinary kallikrein activity (kininogenase activity), using human low molecular weight kininogen.

K. Shimamoto, O. Iimura, M. Nakagawa, 1984, Endocrinologia japonica.

Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.

T. Funahashi, K. Shimamoto, H. Daida, 2007, Journal of atherosclerosis and thrombosis.

Generalized epilepsy in a patient with hypokalemic periodic paralysis and cardiac arrhythmia.

K. Shimamoto, T. Miura, O. Iimura, 1983, Japanese journal of medicine.

Liddle’s Syndrome Caused by a Novel Mutation in the Proline-Rich PY Motif of the Epithelial Sodium Channel β-Subunit

K. Shimamoto, K. Tomita, M. Furuhashi, 2005 .

Time Window for the Contribution of the δ-opioid Receptor to Cardioprotection by Ischemic Preconditioning in the Rat Heart

K. Shimamoto, T. Miura, M. Tanno, 1998, Cardiovascular Drugs and Therapy.

The renal kallikrein-kinin system in renoparenchymal hypertension.

K. Shimamoto, T. Ando, T. Yokoyama, 1989, Advances in experimental medicine and biology.

[Guidelines on Treatment of Hypertension in the Elderly--2002 Revised Version].

T. Ogihara, Y. Ouchi, K. Shimada, 2002, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies.

K. Shimamoto, O. Iimura, Y. Kudoh, 1997, Clinical nephrology.

Does primary stenting preserve cardiac function in myocardial infarction? A case–control study

T. Nakata, K. Shimamoto, H. Sasao, 2000, Heart.

The Optimal Target Blood Pressure for Antihypertensive Treatment in Japanese Elderly Patients with High-Risk Hypertension: A Subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial

T. Ogihara, K. Nakao, T. Fukui, 2008, Hypertension Research.

Relationship between blood pressure level and mortality rate: an 18‐year study conducted in two rural communities in Japan

S. Takagi, K. Shimamoto, S. Saitoh, 2000, Journal of hypertension.

Sex-specific relevance of diabetes to occlusive vascular and other mortality : a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies

R. Collins, D. Levy, E. Rimm, 2019 .

Visceral Obesity in Japanese Patients with Metabolic Syndrome: Reappraisal of Diagnostic Criteria by CT Scan

T. Nakata, K. Shimamoto, M. Hareyama, 2007, Hypertension Research.

Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese.

T. Funahashi, K. Shimamoto, H. Daida, 2007, Journal of atherosclerosis and thrombosis.

Ecto-5'-nucleotidase is not required for ischemic preconditioning in rabbit myocardium in situ.

Jun Sakamoto, Takayuki Miki, K. Shimamoto, 1998, American journal of physiology. Heart and circulatory physiology.

Comparison of long-term clinical outcome after sirolimus-eluting stent implantation in patients with and without hemodialysis.

S. Takagi, K. Shimamoto, Takuto Maeda, 2007, International heart journal.

Persistent insulin-sensitizing effects of sarpogrelate hydrochloride, a serotonin 2A receptor antagonist, in patients with peripheral arterial disease.

T. Nakata, K. Shimamoto, S. Yuda, 2006, Circulation journal : official journal of the Japanese Circulation Society.

Effects of digoxin-specific antibody Fab fragment (Digibind) on blood pressure and renal water-sodium metabolism in 5/6 reduced renal mass hypertensive rats.

K. Shimamoto, M. Nakagawa, N. Ura, 1999, American journal of hypertension.

Genetic factors associated with elevation of uric acid after treatment with thiazide-like diuretic in patients with essential hypertension

J. Higaki, K. Shimamoto, M. Soma, 2019, Hypertension Research.

Electrocardiographic abnormalities in cerebrovascular accidents.

K. Shimamoto, T. Miura, O. Iimura, 1984, Japanese journal of medicine.

Questionnaire survey on the Japanese guidelines for treatment of hypertension in the elderly: 1999 revised version.

T. Ogihara, Y. Ouchi, K. Shimada, 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients

T. Ogihara, K. Shimada, S. Ito, 2009, Hypertension Research.

Serum Ratio of Heart-Type Fatty Acid-Binding Protein to Myoglobin

T. Nakata, K. Shimamoto, M. Furuhashi, 2003, Nephron Clinical Practice.

Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats ‡

K. Shimamoto, T. Miura, N. Ura, 2004, Clinical and experimental pharmacology & physiology.

The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): Protocol, Patient Characteristics, and Blood Pressure during the First 12 Months

T. Ogihara, S. Ito, Y. Yazaki, 2005, Hypertension Research.

Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population

K. Shimamoto, M. Furuhashi, K. Uno, 2001, Heart.

Prognostic Value of Gated Myocardial Perfusion Imaging for Asymptomatic Patients With Type 2 Diabetes

Y. Yamasaki, K. Shimamoto, K. Nakajima, 2010, Diabetes Care.

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2

T. Ogihara, K. Kario, K. Shimada, 2009, Hypertension Research.

Mobile intracardiac calcinosis: a new risk of thromboembolism in patients with haemodialysed end stage renal disease

S. Takagi, K. Shimamoto, N. Moniwa, 1999, Heart.

Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study

K. Kario, S. Ito, K. Shimamoto, 2014, Hypertension Research.

The Risk of Cardiovascular Events in Japanese Hypertensive Patients with Hypercholesterolemia: Sub-Analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a Large-Scale Observational Cohort Study

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2005, Hypertension Research.

Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT).

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2005, Circulation journal : official journal of the Japanese Circulation Society.

Obesity as a risk factor for coronary events in Japanese patients with hypercholesterolemia on low-dose simvastatin therapy.

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2010, Journal of atherosclerosis and thrombosis.

2 Diagnostic Criteria for Dyslipidemia

T. Funahashi, K. Shimamoto, H. Daida, 2007 .

Impact of cigarette smoking on the relationship between body mass index and coronary heart disease: a pooled analysis of 3264 stroke and 2706 CHD events in 378579 individuals in the Asia Pacific region

A. Dobson, M. Woodward, T. Welborn, 2009, BMC Public Health.

Incidence of insulin resistance in obese subjects in a rural Japanese population: The Tanno and Sobetsu study

S. Takagi, S. Saitoh, K. Shimamoto, 2005, Diabetes, obesity & metabolism.

Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients

T. Ogihara, K. Shimada, S. Ito, 2009, Hypertension Research.

Title Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes : a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging

Y. Yamasaki, K. Shimamoto, K. Nakajima, 2017 .

Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages

K. Shimamoto, S. Yuda, Marenao Tanaka, 2017, Scientific Reports.

Circulating Fatty Acid-Binding Protein 4 Concentration Predicts the Progression of Carotid Atherosclerosis in a General Population Without Medication.

K. Shimamoto, S. Yuda, Marenao Tanaka, 2018, Circulation journal : official journal of the Japanese Circulation Society.

Abstract 12916: Elevation of Fatty Acid-Binding Protein 4 is Predisposed by Family History of Hypertension and Contributes to Blood Pressure Elevation

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2012 .

Effects of the Chinese medicine, TSJN on insulin resistance and hypertension in fructose-fed rats.

K. Shimamoto, N. Togashi, N. Ura, 2000, Hypertension research : official journal of the Japanese Society of Hypertension.

Impaired Cardiac Sympathetic Innervation and Myocardial Perfusion Are Related to Lethal Arrhythmia: Quantification of Cardiac Tracers in Patients with ICDs

T. Nakata, K. Shimamoto, S. Yuda, 2010, Journal of Nuclear Medicine.

Human Heart-Type Fatty Acid-Binding Protein as an Early Diagnostic and Prognostic Marker in Acute Coronary Syndrome

T. Nakata, K. Shimamoto, K. Tsuchihashi, 2003, Cardiology.

Relationship between insulin resistance and accumulation of coronary risk factors

S. Takagi, S. Saitoh, K. Shimamoto, 2002, Diabetes, obesity & metabolism.

Does enhanced expression of the Na+-CA2+ exchanger increase myocardial vulnerability to ischemia/reperfusion injury in rabbit hearts?

K. Shimamoto, T. Miura, T. Miki, 2003, Molecular and Cellular Biochemistry.

Protective role of gap junctions in preconditioning against myocardial infarction.

K. Shimamoto, T. Miura, A. Kuno, 2004, American journal of physiology. Heart and circulatory physiology.

Expert recommendations on the challenges of hypertension in Asia

K. Shimamoto, T. Saruta, S. Baek, 2008, International journal of clinical practice.

A Review of Cohort Studies on the Association Between History of Diabetes Mellitus and Occurrence of Cancer.

S. Takagi, K. Shimamoto, M. Mori, 2000, Asian Pacific journal of cancer prevention : APJCP.

Delta-opioid receptor activation before ischemia reduces gap junction permeability in ischemic myocardium by PKC-epsilon-mediated phosphorylation of connexin 43.

K. Shimamoto, M. Nishihara, T. Miura, 2007, American journal of physiology. Heart and circulatory physiology.

Quadricuspid aortic valve associated with aortic stenosis and regurgitation: report of a case and a review of the literature

K. Shimamoto, S. Yuda, T. Miura, 2007, Journal of Medical Ultrasonics.

Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan

T. Ogihara, K. Shimada, S. Ito, 2012, Hypertension Research.

Relationship between hepatocellular carcinoma and impaired glucose tolerance among Japanese.

S. Takagi, K. Shimamoto, M. Mori, 2006, Hepato-gastroenterology.

Kallikrein-induced uterine contraction independent of kinin formation.

K. Shimamoto, J. Chao, H. Margolius, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Immunoassays for the determination of human tissue kallikrein (TK) in different body fluids based on monoclonal antibodies.

K. Shimamoto, E. Fink, G. Godec, 1992, Agents and actions. Supplements.

Other health matters to be considered for the Asian population: hypertensive patients at high risk

K. Shimamoto, C. Liau, Y.t. Lee, 2006 .

Effect of TNF-alpha--converting enzyme inhibitor on insulin resistance in fructose-fed rats.

K. Shimamoto, N. Togashi, N. Ura, 2002, Hypertension.

Clinical pathology and treatment of renin-angiotensin system 4. Renin-angiotensin system and insulin resistance.

K. Shimamoto, T. Miura, 2007, Internal medicine.

The pathophysiological role of renal dopamine and kallikrein in deoxycorticosterone acetate (DOCA)-salt treated rats.

K. Shimamoto, O. Iimura, N. Ura, 1995, Clinical and experimental hypertension.

Purification of human low molecular weight kininogen and its application for a simple ND sensitive method for determination of human urinary kallikrein activity.

K. Shimamoto, T. Nishitani, H. Ishida, 1986, Advances in Experimental Medicine and Biology.

The excretion of human urinary kallikrein quantity and activity in normal and low renin subgroups of essential hypertension.

K. Shimamoto, S. Tanaka, O. Iimura, 1983, Clinical and experimental hypertension. Part A, Theory and practice.

Significance of renal kininases in patients with Cushing's syndrome.

K. Shimamoto, O. Iimura, Y. Takagawa, 1995, Clinical and experimental hypertension.

Measurement of urinary kallikrein acitvity by kinin radioimmunoassay.

K. Shimamoto, M. Miyahara, T. Ando, 1979, Japanese circulation journal.

Surveillance study for creating the national clinical database relating to ECG-gated myocardial perfusion SPECT of asymptomatic ischemic heart disease in patients with type-2 diabetes mellitus: J-ACCESS 2 study design

Y. Yamasaki, K. Shimamoto, T. Nishimura, 2008, Annals of nuclear medicine.

Role of endocrinological factors in the pathogenesis of idiopathic edema.

K. Shimamoto, M. Miyahara, T. Ando, 1980, The Tohoku journal of experimental medicine.

Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke: A Randomized Clinical Trial and Meta-analysis.

K. Shimada, S. Ito, J. Higaki, 2019, JAMA neurology.

Predicting the Need for an Implantable Cardioverter Defibrillator Using Cardiac Metaiodobenzylguanidine Activity Together with Plasma Natriuretic Peptide Concentration or Left Ventricular Function

T. Nakata, K. Shimamoto, K. Uno, 2008, Journal of Nuclear Medicine.

Guidelines for Clinical Use of Cardiac Nuclear Medicine (JCS 2010) : Digest Version

Junichi Yamazaki, Masunori Matsuzaki, Shoichi Senda, 2012 .

Influence of Hypertension on the Incidence of Cardiovascular Disease in Two Rural Communities in Japan: The Tanno-Soubetsu Study

S. Takagi, K. Shimamoto, S. Saitoh, 2007, Hypertension Research.

Giant endocardial blood cyst in left ventricle resected by transaortic valve approach.

K. Shimamoto, S. Tanaka, O. Iimura, 1993, Chest.

Variation in OSBPL10 is associated with dyslipidemia

T. Ogihara, Y. Kaneda, R. Morishita, 2010, Hypertension Research.

Development and Progression of Atherosclerotic Disease in Relation to Insulin Resistance and Hyperinsulinemia

S. Takagi, K. Shimamoto, T. Miura, 2005, Hypertension Research.

New technique for time series analysis combining the maximum entropy method and non-linear least squares method: its value in heart rate variability analysis

K. Yamakoshi, K. Shimamoto, Y. Sawada, 1997, Medical and Biological Engineering and Computing.

Impaired myocardial accumulation of 15-(p-iodophenyl)-9-(R,S)-methylpentadecanoic acid in a patient with hypertrophic cardiomyopathy and exercise-induced ischemia due to vasospasm

T. Nakata, K. Shimamoto, K. Tsuchihashi, 2000, Annals of nuclear medicine.

Fenofibrate improves insulin sensitivity in connection with intramuscular lipid content, muscle fatty acid-binding protein, and beta-oxidation in skeletal muscle.

K. Shimamoto, M. Furuhashi, N. Ura, 2002, The Journal of endocrinology.

Studies on Hemodynamic Instability in Paroxysmal Supraventricular Tachycardia: Noninvasive Evaluations by Head‐Up Tilt Testing and Power Spectrum Analysis on Electrocardiographic RR Variation

T. Nakata, K. Shimamoto, K. Uno, 2000, Pacing and clinical electrophysiology : PACE.

Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning.

K. Shimamoto, T. Miura, O. Iimura, 1992, Cardiovascular research.

Rationale for time-qualified reference standards for 24-hour blood pressure values and their circadian rhythms in Japanese normotensive adults: a study by the Ambulatory Blood Pressure Monitoring Research Group.

T. Ogihara, K. Shimamoto, H. Hayashi, 1999, Japanese circulation journal.

[Adiponectin levels and coronary risk factors in the elderly].

S. Takagi, K. Shimamoto, H. Ohnishi, 2004, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

Low alpha-synuclein levels in the blood are associated with insulin resistance

Y. Kaneda, R. Morishita, T. Katsuya, 2015, Scientific Reports.

Predominant expression of Sir2alpha, an NAD-dependent histone deacetylase, in the embryonic mouse heart and brain.

K. Shimamoto, Y. Horio, T. Miura, 2004, FEBS letters.

Activation of kinins on myocardial ischemia.

K. Shimamoto, T. Miura, O. Iimura, 1992, Agents and actions. Supplements.

Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients

K. Shimamoto, S. Yuda, N. Fujii, 2008, Heart and Vessels.

A Polymorphism Regulates CYP4A11 Transcriptional Activity and Is Associated With Hypertension in a Japanese Population

T. Ogihara, K. Node, T. Katsuya, 2008, Hypertension.

Bradykinin release and inactivation in brain of rats submitted to an experimental model of Alzheimer's disease

K. Shimamoto, H. Buck, T. Viel, 2006, Peptides.

Differential regulation of hypoxanthine and xanthine by obesity in a general population

K. Shimamoto, Marenao Tanaka, M. Furuhashi, 2020, Journal of diabetes investigation.

Hepatocyte growth factor and 24-hour ambulatory blood pressure monitoring.

S. Takagi, K. Shimamoto, T. Miura, 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

Hypocalcemic cardiomyopathy in a patient with idiopathic hypoparathyroidism.

Y. Miyazaki, K. Shimamoto, S. Tanaka, 1992, Internal medicine.

Left ventricular hypertrophy causes different changes in longitudinal, radial, and circumferential mechanics in patients with hypertension: a two-dimensional speckle tracking study.

K. Shimamoto, S. Yuda, T. Miura, 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[Epidemiologic study on metabolic syndrome--comparison between Japan and western countries].

K. Shimamoto, 2004, Nihon rinsho. Japanese journal of clinical medicine.

The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension

Y. Imai, K. Shimamoto, H. Itoh, 2014, Hypertension Research.

Effects of Norepinephrine and Angiotensin II on Plasma Atrial Natriuretic Peptide Concentration in Humans

Hironori Murakami, K. Shimamoto, O. Iimura, 1988, Journal of Cardiovascular Pharmacology.

Japan Arteriosclerosis Longitudinal Study-Existing Cohorts Combine (JALS-ECC): rationale, design, and population characteristics.

K. Asayama, M. Kikuya, T. Ohkubo, 2008, Circulation journal : official journal of the Japanese Circulation Society.

Tissue-specific impairment of insulin signaling in vasculature and skeletal muscle of fructose-fed rats.

K. Shimamoto, M. Furuhashi, N. Togashi, 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[Hypertension: The Points of Management of Hypertension for All Physicians--Based on the JSH 2014 Hypertension Guidelines--Editorial: Characteristics and major revised points of JSH2014-difference from JSH2009].

K. Shimamoto, 2015, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Alteration in Erythropoietin-Induced Cardioprotective Signaling by Postinfarct Ventricular Remodeling

K. Shimamoto, M. Nishihara, T. Miura, 2006, Journal of Pharmacology and Experimental Therapeutics.

In vivo concentrations of kinins and angiotensins.

K. Shimamoto, O. Iimura, M. Nakagawa, 1990, Hormone and metabolic research. Supplement series.

Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging

Y. Yamasaki, K. Shimamoto, K. Nakajima, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Measurement of circulating kinins, their changes by inhibition of kininase II and their possible blood pressure lowering effect.

K. Shimamoto, O. Iimura, 1987, Agents and actions. Supplements.

The mechanism of the hypotensive effect of captopril (converting enzyme inhibitor) with special reference to the kallikrein-kinin and renin-angiotensin systems.

S. Hosoda, K. Shimamoto, T. Ando, 1986, Japanese journal of medicine.

Role of renin-angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effects of converting enzyme inhibitor, alacepril.

S. Hosoda, K. Shimamoto, T. Ando, 1987, Clinical and Experimental Hypertension Part A Theory and Practice.

Impact of abnormal glucose tolerance, hypertension and other risk factors on coronary artery disease.

S. Takagi, K. Shimamoto, T. Miura, 2007, Circulation journal : official journal of the Japanese Circulation Society.

Effects of Hypertension and Type 2 Diabetes Mellitus on the Risk of Total Cardiovascular Events in Japanese Patients with Hypercholesterolemia: Implications from the Japan Lipid Intervention Trial (J-LIT)

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2007, Hypertension Research.

Relation of hypertension and glucose tolerance impairment in elderly people to the development of arteriosclerosis: Investigation using pulse wave velocity *

S. Takagi, K. Shimamoto, H. Akasaka, 2005, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[Relation of hypertension and glucose tolerance impairment in elderly people to the development of arteriosclerosis--investigation using pulse wave velocity].

S. Takagi, K. Shimamoto, H. Ohnishi, 2003 .

[Symposium on edema. (2) Clinics of edema. V) A role of endocrinological factors in edema of unknown etiology with special reference to idiopathic edema (author's transl)].

K. Shimamoto, M. Miyahara, 1978, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

II Clinics of Edema (5) A Role of Endocrinological Factors in Edema of Unknown Etiology with Special Reference to Idiopathic Edema

K. Shimamoto, M. Miyahara, 1979 .

Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies

R. Collins, R. Kronmal, E. Vartiainen, 2018, The lancet. Diabetes & endocrinology.

Short-term effectiveness of an individual counseling program for impaired fasting glucose and mild type 2 diabetes in Japan: a multi-center randomized control trial.

K. Shimamoto, H. Ueshima, A. Okayama, 2007, Asia Pacific journal of clinical nutrition.

Response to: Noninvasive Assessment of Left Atrial Function by Strain Rate Imaging in Patients with Hypertension: A Possible Beneficial Effect of Renin-Angiotensin System Inhibition on Left Atrial Function

K. Shimamoto, S. Yuda, Nobuaki Kokubu, 2008, Hypertension Research.

[Metabolic syndrome and cardiovascular diseases].

E. Bonora, K. Shimamoto, 2008, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Plasma prolactin levels in patients with essential hypertension, malignant hypertension and secondary hypertension.

K. Shimamoto, T. Ando, Y. Nakahashi, 1985, Japanese journal of medicine.

Focal Myocardial Arrhythmogenic Substrates Detected in Brugada Syndrome Can Contribute to Characteristic Propagating Mode of Induced Ventricular Fibrillation

Toru Takahashi, K. Shimamoto, K. Uno, 2003 .

[Night-eating syndrome].

S. Takagi, K. Shimamoto, S. Saitoh, 2001, Nihon rinsho. Japanese journal of clinical medicine.

Fusion of bone marrow‐derived cells with renal tubules contributes to renal dysfunction in diabetic nephropathy

M. Fujimiya, K. Shimamoto, Marenao Tanaka, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A comparative study of the measurement of urinary kallikrein by various methods in patients with essential hypertension and patients with proteinuria.

K. Shimamoto, O. Iimura, M. Nakagawa, 1986, Advances in experimental medicine and biology.

Plasma calcitonin gene‐related peptide levels in patients with various hypertensive diseases

K. Shimamoto, M. Nakagawa, N. Ura, 1992, Journal of hypertension.

Y. Yamasaki, K. Shimamoto, T. Nishimura, 2008, Annals of nuclear medicine.

Ser9 phosphorylation of mitochondrial GSK-3beta is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis.

K. Shimamoto, Y. Horio, S. Ishikawa, 2008, American journal of physiology. Heart and circulatory physiology.

Detection of Cardiac Calcinosis in Hemodialysis Patients by Whole-Body Scintigraphy with 99m-Technetium Methylene Diphosphonate

T. Nakata, K. Shimamoto, H. Takizawa, 2000, American Journal of Nephrology.

Intracranial pheochromocytoma--a case of noradrenaline-secreting glomus jugulare tumor.

K. Shimamoto, O. Iimura, Y. Kudoh, 1995, Japanese circulation journal.

Hypertensive Hypertrophied Myocardium Is Vulnerable to Infarction and Refractory to Erythropoietin-Induced Protection